Home > Insider Trading > Filing (0001127602-11-021342)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874663	Alkermes Inc	ALKS	Pharmaceutical Preparations (2834)	232472830

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1235598	M James Frates	852 Winter St. Waltham MA 02451	Svp, Cfo & Treasurer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-07-08	200	$4.77	86,394	No	4	M	Direct
Common Stock	Disposition	2011-07-08	200	$20.00	86,194	No	4	S	Direct
Common Stock	Disposition	2011-07-08	1,588	$19.52	84,606	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non Qualified Stock Option (Right to Buy)	Disposition	2011-07-08	200	$0.00	200	$4.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
22,296	2003-07-18	2012-07-18	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,000	Indirect	By Sons

Footnotes

This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Net share settlement to satisfy tax withholding obligations in connection with the 7/8/11 vesting of the performance-based restricted stock award of 5,000 shares pursuant to the occurrence of a five day trailing average closing price of $19 or more per share of the Company's common stock as reported on NASDAQ.
The option becomes exercisable in equal annual installments over a four year period, at the rate of 25% per year commencing one year after the grant date.